Dr. Alex Marson, a medical doctor and scientist, joins Andrew Huberman to discuss the workings of the immune system, cancer treatments, and gene editing technologies. The conversation highlights the convergence of biology, DNA sequencing, and molecular biology, enabling interventions at the root causes of diseases. Marson details the roles of innate and adaptive immune systems, T-cells, and B-cells in protecting against infections and maintaining balance within the body. The discussion covers cancer's genetic basis, mutations, and the potential of immunotherapy, including CAR T-cells, to target cancer cells. Marson shares the success story of Emily Whitehead, the first pediatric patient cured with CAR T-cells, and explores the transformative CRISPR technology for rewriting DNA sequences and programming cell behavior.
Outlines
Part 1: Introduction to Immunotherapy
Part 2: The Immune System & Systemic Health
Part 3: Understanding Cancer & Risk Factors
Part 4: CAR T-cells & CRISPR Technology
Part 5: Advanced Gene Editing & Delivery
Part 6: Future Delivery & Therapeutic Innovations
Part 7: Ethics, Diversity, and Human Depth
Part 8: Outlook & Conclusion
Sign in to continue reading, translating and more.